These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 38596238)

  • 1. Genetic modifiers of synucleinopathies-lessons from experimental models.
    Lee RMQ; Koh TW
    Oxf Open Neurosci; 2023; 2():kvad001. PubMed ID: 38596238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midbrain organoids with an
    Mohamed NV; Sirois J; Ramamurthy J; Mathur M; Lépine P; Deneault E; Maussion G; Nicouleau M; Chen CX; Abdian N; Soubannier V; Cai E; Nami H; Thomas RA; Wen D; Tabatabaei M; Beitel LK; Singh Dolt K; Karamchandani J; Stratton JA; Kunath T; Fon EA; Durcan TM
    Brain Commun; 2021; 3(4):fcab223. PubMed ID: 34632384
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies.
    Kawahata I; Finkelstein DI; Fukunaga K
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
    Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
    Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
    Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
    Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
    Peelaerts W; Baekelandt V
    J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of SNCA gene expression: implications to synucleinopathies.
    Tagliafierro L; Chiba-Falek O
    Neurogenetics; 2016 Jul; 17(3):145-57. PubMed ID: 26948950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein biology in Lewy body diseases.
    Kim WS; Kågedal K; Halliday GM
    Alzheimers Res Ther; 2014; 6(5):73. PubMed ID: 25580161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies.
    Chopra A; Outeiro TF
    Brain; 2024 Jan; 147(1):81-90. PubMed ID: 37526295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
    Hartlage-Rübsamen M; Bluhm A; Moceri S; Machner L; Köppen J; Schenk M; Hilbrich I; Holzer M; Weidenfeller M; Richter F; Coras R; Serrano GE; Beach TG; Schilling S; von Hörsten S; Xiang W; Schulze A; Roßner S
    Acta Neuropathol; 2021 Sep; 142(3):399-421. PubMed ID: 34309760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MED13 and glycolysis are conserved modifiers of α-synuclein-associated neurodegeneration.
    Ren M; Yang Y; Heng KHY; Ng LY; Chong CY; Ng YT; Gorur-Shandilya S; Lee RMQ; Lim KL; Zhang J; Koh TW
    Cell Rep; 2022 Dec; 41(12):111852. PubMed ID: 36543134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are synucleinopathies prion-like disorders?
    Angot E; Steiner JA; Hansen C; Li JY; Brundin P
    Lancet Neurol; 2010 Nov; 9(11):1128-38. PubMed ID: 20846907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious Agents as Potential Drivers of α-Synucleinopathies.
    Linard M; Ravier A; Mougué L; Grgurina I; Boutillier AL; Foubert-Samier A; Blanc F; Helmer C
    Mov Disord; 2022 Mar; 37(3):464-477. PubMed ID: 35040520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
    Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
    Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective.
    Knecht L; Folke J; Dodel R; Ross JA; Albus A
    Neurotherapeutics; 2022 Sep; 19(5):1489-1502. PubMed ID: 36083395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies.
    Spillantini MG
    Parkinsonism Relat Disord; 1999 Dec; 5(4):157-62. PubMed ID: 18591134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions.
    Walker L; Stefanis L; Attems J
    J Neurochem; 2019 Sep; 150(5):467-474. PubMed ID: 30892688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.